ClinicalTrials.Veeva

Menu

Evaluation of Optical Coherence Tomography. (ESSO)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Age-Related Macular Degeneration
Choroidal Vessels; Anastomosis

Treatments

Other: tests

Study type

Observational

Funder types

Other

Identifiers

NCT01080898
IDRCB 2009-A00670-57 (Other Identifier)
K080904

Details and patient eligibility

About

Determination of the sensitivity and specificity of different combinations of imaging techniques (spectral domain optical coherence tomography, fundus photography and fluorescein angiography) used for the diagnosis of choroidal neovessels complicating age -related macular degeneration. This information will help to determine the choice of the most suitable combination for the above diagnosis.

Full description

The following combinations will be studied: spectral domain optical coherence tomography (OCT) + fundus photography; fluorescein angiography + fundus photography and the combination of all three techniques (OCT+ fundus photography + fluorescein angiography).The sensitivity and specificity of the latter combination will be assessed by comparison with the results for this combination reported by several readers. Inter- and intra-observer reproducibility of the different combinations will also be studied.

Enrollment

151 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age> 50 years
  • First visit for suspicion of choroidal neo-vessels complicating age related macular degeneration
  • Fundus color photographs , FLUORESCEIN angiography and OCT prescription

Exclusion criteria

  • Age < 50 years
  • Diabetes
  • Central vein occlusion Macular hole Epi-retinal membrane Retinal detachment Macular hemorrhage more than the 1/3 of the lesion
  • History of macular laser, PDT or intra-vitreal injection

Trial design

151 participants in 1 patient group

DMLA patients
Description:
patients \> 50 years with suspicion of choroidal neo-vessels complicating age related macular degeneration (DMLA)
Treatment:
Other: tests

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems